Abstract
Reported here is an exceptional case of acute retroviral syndrome resembling septic shock that occurred in a chronic HIV-infected patient shortly following planned interruption of antiretroviral treatment. The therapeutic strategy, which is aimed at improving the immunological control of HIV infection, can therefore be deleterious in chronically infected patients and should be avoided outside of closely monitored clinical trials.
Similar content being viewed by others
References
Lori F, Foli A, Lisziewiz J (2002) Structured treatment interruptions as a potential alternative therapeutic regimen for HIV-infected patients: a review of recent clinical data and future prospects. J Antimicrob Chemother 50:155–160
Palella F, Delaney K, Moorman A, et al (1998) Declining morbidity and mortality among patients with advanced HIV infection. N Engl J Med 338:853–860
Carcelain G, Tubiana R, Samri A, Calvez V, Delaugerre C, Agut H, Katlama C, Autran B (2000) Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection. J Virol 75:234–241
Chun TW, Stuyver L, Mizell SB, Ehler L, Mican JO, Baseler M, Lloyd A, Nowak M, Fauci A (1997) Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci 94:13193–13197
Harrigan PR, Whaley M, Montaner J (1999) Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy. AIDS 13:F59–F62
Frost S, Martinez-Picado J, Ruiz L, Clotet B, Leight Brown A (2002) Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection. J Virol 76:968–979
Hoen B, Burgard M, Fournier I, Lacabaratz C, Raffi F, Lafauri M, Livrozet JM, Rouzioux C, Venet A, Aboulker JP (2001) Structured treatment interruptions (STI) in acute seroconverters: interim results of the multicenter prospective PRIMSTOP pilot trial (ANRS 100). 9th Conference on Retroviruses and Retroviral Infection. Abstract 530
Walensky RP, Goldie SJ, Sax PE, Weinstein MC, Paltiel AD, Kimmel AD, Seage GR, Losina E, Zhang H, Islam R, Freedberg KA (2000) Treatment of primary HIV infection: projecting outcomes of immediate, interrupted or delayed therapy. J Acquir Immune Defic Syndr 31:27–37
Hirschel B, Fagard C, Oxenius A, Gunthard H, Garcia F (2001) SSITT: a prospective trial of treatment interruptions in HIV infection. 9th Conference on Retroviruses and Retroviral Infection. Abstract 528
Oxenius A, Price DA, Gunthar HF, Dawson SJ, Fagard C, Perrin L, Fischer M, Weber R, Plana M, Garcia F, Hirschel B, Mclean A, Phillips RE (2002) Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhace viral control in chronic infection. Proc Natl Acad Sci USA 99:13747–13752
Lawrence J, Mayers D, Hupler K, Collins G, Abrams D, Reisler R, Crane L, Shmetter B, Dionne T, Saldanha J, Jones M, Baxter J (2003) A randomised trial examining structured treatment interruption for patients failing therapy with multi-drug resistant HIV. In: Program and abstracts, 10th Conference on Retroviruses and Retroviral Infection. Oral abstract no. 67
Katlama C, Dominguez S, Duvivier C, Delaugerre C, Peytavin G, Legrad M, Calvez V, Gourlain K, Costagliola D (2003) Long-term benefit of treatment interruption in salvage therapy. In: Program and abstracts, 10th Conference on Retroviruses and Retroviral Infection. Oral abstract no. 68
Kahn J, Walker B (1998) Acute human immunodeficiency virus type 1 infection. N Engl J Med 339:33–39
Eerens F, Van Cleemput J, Petermans WE (1999) A probable primary HIV infection associated with acute non-specific myocarditis causing severe dilated cardiomyopathy. Acta Clin Belg 54:220–222
Schindler JM, Neftel KA (1990) Simultaneous primary infection with HIV and CMV leading to severe pancytopenia, hepatitis, nephritis, perimyocarditis, myosisits, and alopecia totalis. Klin Wochenschr 68:237–240
Pitcher CJ, Quittner C, Peterson DM, Connor M, Koup R, Maino V, Picker LJ (1999) HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med 5:1518–1525
Currie PF, Boon NA (2003) Immunopathogenesis of HIV-related heart muscle disease: current perspectives. AIDS 17 (Suppl 1):21–28
Moroni M, Antinori S (2003) HIV direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era. AIDS 17 (Suppl 1):51–64
Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA (2003) Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42:466–472
Falcó V, Crespo M, Ribera E (2003) Lactic acidosis related to nucleoside therapy in HIV-infected patients. Expert Opin Pharmacother 4:1321–1329
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Crespo, M., Paradiñeiro, J.C., Ribera, E. et al. A Case of Multiorgan Failure Following Interruption of Antiretroviral Treatment. Eur J Clin Microbiol Infect Dis 23, 63–65 (2004). https://doi.org/10.1007/s10096-003-1049-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-003-1049-5